Gd-EOB-DTPA-enhanced T1 Map for Predicting Postoperative Liver Failure
NCT05592106 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2022-10-24
Summary
Researchers designed this study to compare the value of the conventional circular region-of-interest (ROI) and whole-liver histogram-based analysis on gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced T1 map for predicting postoperative liver failure (PHLF). Researchers collected and analyzed the data of patients who underwent partial hepatectomy for focal liver lesions. Researchers drew circular ROIs on Gd-EOB-DTPA-enhanced T1 maps to get the mean T1 values. Researchers used a multiparametric analysis software to get histogram parameters. Then researchers compared the differences of these parameters between the PHLF group and non-PHLF group.
Conditions
- Liver Failure
Interventions
- DIAGNOSTIC_TEST
-
T1 mapping on gadoxetic acid-enhanced MRI
All subjects underwent 1.5T Gd-EOB-DTPA-enhanced MRI including pre-contrast and hepatobiliary-phase T1 mapping.
Sponsors & Collaborators
-
Shanghai Zhongshan Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-10
- Primary Completion
- 2021-12-20
- Completion
- 2022-10-13
Countries
- China
Study Locations
More Related Trials
-
Evaluation of Gd-EOB-DTPA MRI for Detection and Characterization of Liver Nodules in Cirrhotic Patients Undergoing Liver Transplantation and Potential Impact on Transplant Eligibility
NCT03342677 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Remnant Liver Function in ALPPS by Gd-EOB-DTPA Enhanced MRI
NCT04559451 ·Status: UNKNOWN
-
Identification of Hepatic Lesions
NCT00307866 ·Status: COMPLETED ·Phase: PHASE3
-
Liver Fat Quantification by Magnetic Resonance Imaging (MRI) - Prediction of Postoperative Complications
NCT01234714 ·Status: COMPLETED
-
Prediction of Donor Liver Adipose Content by Magnetic Resonance Imaging
NCT02873507 ·Status: WITHDRAWN ·Phase: NA
-
Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma
NCT01490203 ·Status: COMPLETED
-
Hepatic Steatosis and Pituitary Gland Failure, Evaluation by Nuclear Magnetic Resonance (NMR) Imaging
NCT02814240 ·Status: COMPLETED ·Phase: NA
-
Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis
NCT03142698 ·Status: UNKNOWN ·Phase: NA
-
To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease
NCT07149571 ·Status: RECRUITING
-
T1-mapping by Cardiovascular Magnetic Resonance Imaging to Assess Non-Alcoholic Fatty Liver Disease
NCT04220450 ·Status: UNKNOWN
-
A Machine Learning Architecture to Predict Post-Hepatectomy Liver Failure Using Liver Regeneration Biomarkers and Time-Phased Data
NCT05779098 ·Status: COMPLETED
-
Ga-68 Dolacga PET Scan in HCC Under RFA
NCT06792097 ·Status: NOT_YET_RECRUITING
-
Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI)
NCT01234701 ·Status: COMPLETED
-
Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease
NCT02860884 ·Status: COMPLETED
-
Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure
NCT07275554 ·Status: RECRUITING
-
Evaluation of Hepatic Function Using Gadoxetic Acid Enhanced MRI
NCT02854371 ·Status: COMPLETED ·Phase: PHASE4
-
Magnetic Resonance Imaging in the Evaluation of Liver Fibrosis
NCT01572064 ·Status: COMPLETED ·Phase: NA
-
Radiomics for Diagnosing Liver Diseases and Evaluating Progression
NCT03221049 ·Status: UNKNOWN
-
Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease
NCT03635541 ·Status: UNKNOWN
-
Magnetic Resonance Imaging (MRI) Fat Quantification of the Liver
NCT02682173 ·Status: COMPLETED ·Phase: NA
-
Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver Disease
NCT02658786 ·Status: WITHDRAWN
-
Predicting Complications of Hepatolithiasis After Hepatectomy
NCT05556434 ·Status: UNKNOWN
-
Usefulness of Multi-parametric, Quantitative MR Imaging for Staging of Hepatic Fibrosis in the Patients With Chronic Hepatitis
NCT01981421 ·Status: UNKNOWN
-
Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC
NCT04212286 ·Status: COMPLETED ·Phase: NA
-
Functional MRI to Determine Severity of Cirrhosis
NCT03623360 ·Status: UNKNOWN